272 related articles for article (PubMed ID: 24886351)
1. Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia.
Hagihara H; Ohira K; Takao K; Miyakawa T
Mol Brain; 2014 May; 7():41. PubMed ID: 24886351
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic immaturity of the hippocampus and prefrontal cortex in patients with alcoholism.
Murano T; Koshimizu H; Hagihara H; Miyakawa T
Sci Rep; 2017 Mar; 7():44531. PubMed ID: 28295046
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia.
Petralia MC; Ciurleo R; Saraceno A; Pennisi M; Basile MS; Fagone P; Bramanti P; Nicoletti F; Cavalli E
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32260267
[TBL] [Abstract][Full Text] [Related]
4. Developmental expression profile of quaking, a candidate gene for schizophrenia, and its target genes in human prefrontal cortex and hippocampus shows regional specificity.
Lauriat TL; Shiue L; Haroutunian V; Verbitsky M; Ares M; Ospina L; McInnes LA
J Neurosci Res; 2008 Mar; 86(4):785-96. PubMed ID: 17918747
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development.
Choi KH; Zepp ME; Higgs BW; Weickert CS; Webster MJ
J Psychiatry Neurosci; 2009 Nov; 34(6):450-8. PubMed ID: 19949721
[TBL] [Abstract][Full Text] [Related]
7. Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia.
Mauney SA; Athanas KM; Pantazopoulos H; Shaskan N; Passeri E; Berretta S; Woo TU
Biol Psychiatry; 2013 Sep; 74(6):427-35. PubMed ID: 23790226
[TBL] [Abstract][Full Text] [Related]
8. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.
Arion D; Corradi JP; Tang S; Datta D; Boothe F; He A; Cacace AM; Zaczek R; Albright CF; Tseng G; Lewis DA
Mol Psychiatry; 2015 Nov; 20(11):1397-405. PubMed ID: 25560755
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function.
Miller BH; Zeier Z; Xi L; Lanz TA; Deng S; Strathmann J; Willoughby D; Kenny PJ; Elsworth JD; Lawrence MS; Roth RH; Edbauer D; Kleiman RJ; Wahlestedt C
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3125-30. PubMed ID: 22315408
[TBL] [Abstract][Full Text] [Related]
10. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
Broadbelt K; Jones LB
J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
[TBL] [Abstract][Full Text] [Related]
11. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia.
Arion D; Unger T; Lewis DA; Levitt P; Mirnics K
Biol Psychiatry; 2007 Oct; 62(7):711-21. PubMed ID: 17568569
[TBL] [Abstract][Full Text] [Related]
12. Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.
Pratt JA; Winchester C; Egerton A; Cochran SM; Morris BJ
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S465-70. PubMed ID: 18311160
[TBL] [Abstract][Full Text] [Related]
13. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia.
Barch DM; Carter CS; Braver TS; Sabb FW; MacDonald A; Noll DC; Cohen JD
Arch Gen Psychiatry; 2001 Mar; 58(3):280-8. PubMed ID: 11231835
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.
Middleton FA; Mirnics K; Pierri JN; Lewis DA; Levitt P
J Neurosci; 2002 Apr; 22(7):2718-29. PubMed ID: 11923437
[TBL] [Abstract][Full Text] [Related]
15. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.
Hashimoto T; Volk DW; Eggan SM; Mirnics K; Pierri JN; Sun Z; Sampson AR; Lewis DA
J Neurosci; 2003 Jul; 23(15):6315-26. PubMed ID: 12867516
[TBL] [Abstract][Full Text] [Related]
16. ΔFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes.
Dietz DM; Kennedy PJ; Sun H; Maze I; Gancarz AM; Vialou V; Koo JW; Mouzon E; Ghose S; Tamminga CA; Nestler EJ
Neuropsychopharmacology; 2014 Feb; 39(3):538-44. PubMed ID: 24067299
[TBL] [Abstract][Full Text] [Related]
17. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs.
O'Connor JA; Muly EC; Arnold SE; Hemby SE
Schizophr Res; 2007 Feb; 90(1-3):28-40. PubMed ID: 17141476
[TBL] [Abstract][Full Text] [Related]
18. Sex-Specific Differences in the Transcriptome of the Human Dorsolateral Prefrontal Cortex in Schizophrenia.
Yu Z; Ueno K; Funayama R; Sakai M; Nariai N; Kojima K; Kikuchi Y; Li X; Ono C; Kanatani J; Ono J; Iwamoto K; Hashimoto K; Kinoshita K; Nakayama K; Nagasaki M; Tomita H
Mol Neurobiol; 2023 Feb; 60(2):1083-1098. PubMed ID: 36414910
[TBL] [Abstract][Full Text] [Related]
19. EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia.
Johnstone AL; O'Reilly JJ; Patel AJ; Guo Z; Andrade NS; Magistri M; Nathanson L; Esanov R; Miller BH; Turecki G; Brothers SP; Zeier Z; Wahlestedt C
Neurobiol Dis; 2018 Nov; 119():149-158. PubMed ID: 30099093
[TBL] [Abstract][Full Text] [Related]
20. Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder.
Kunii Y; Hino M; Matsumoto J; Nagaoka A; Nawa H; Kakita A; Akatsu H; Hashizume Y; Yabe H
Sci Rep; 2019 Oct; 9(1):14877. PubMed ID: 31619735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
